Study of Iguratimod in Sjögren's Syndrome

NCT03023592 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sjogren's Syndrome

Interventions

DRUG: Iguratimod

Sponsor

Peking Union Medical College Hospital